Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Treatment of Lyme Arthritis.

Steere AC.

J Rheumatol. 2019 Aug;46(8):871-873. doi: 10.3899/jrheum.190320. No abstract available.

PMID:
31371661
2.

Borrelia burgdorferi peptidoglycan is a persistent antigen in patients with Lyme arthritis.

Jutras BL, Lochhead RB, Kloos ZA, Biboy J, Strle K, Booth CJ, Govers SK, Gray J, Schumann P, Vollmer W, Bockenstedt LK, Steere AC, Jacobs-Wagner C.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13498-13507. doi: 10.1073/pnas.1904170116. Epub 2019 Jun 17.

3.

CD1b presents self and Borrelia burgdorferi diacylglycerols to human T cells.

Reinink P, Souter MNT, Cheng TY, van Gorkom T, Lenz S, Kubler-Kielb J, Strle K, Kremer K, Thijsen SFT, Steere AC, Godfrey DI, Pellicci DG, Moody DB, Van Rhijn I.

Eur J Immunol. 2019 May;49(5):737-746. doi: 10.1002/eji.201847949. Epub 2019 Mar 20.

4.

Interferon-gamma production in Lyme arthritis synovial tissue promotes differentiation of fibroblast-like synoviocytes into immune effector cells.

Lochhead RB, Ordoñez D, Arvikar SL, Aversa JM, Oh LS, Heyworth B, Sadreyev R, Steere AC, Strle K.

Cell Microbiol. 2019 Feb;21(2):e12992. doi: 10.1111/cmi.12992. Epub 2019 Jan 4.

PMID:
30550623
5.

Direct Diagnostic Tests for Lyme Disease.

Schutzer SE, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, Gerald NJ, Gomes-Solecki M, Kintrup M, Ledizet M, Levin AE, Lewinski M, Liotta LA, Marques A, Mead PS, Mongodin EF, Pillai S, Rao P, Robinson WH, Roth KM, Schriefer ME, Slezak T, Snyder JL, Steere AC, Witkowski J, Wong SJ, Branda JA.

Clin Infect Dis. 2019 Mar 5;68(6):1052-1057. doi: 10.1093/cid/ciy614.

6.

Robust interferon signature and suppressed tissue repair gene expression in synovial tissue from patients with postinfectious, Borrelia burgdorferi-induced Lyme arthritis.

Lochhead RB, Arvikar SL, Aversa JM, Sadreyev RI, Strle K, Steere AC.

Cell Microbiol. 2019 Feb;21(2):e12954. doi: 10.1111/cmi.12954. Epub 2018 Oct 17.

PMID:
30218476
7.

Correlation of Lyme Disease-Associated IgG4 Autoantibodies With Synovial Pathology in Antibiotic-Refractory Lyme Arthritis.

Sulka KB, Strle K, Crowley JT, Lochhead RB, Anthony R, Steere AC.

Arthritis Rheumatol. 2018 Nov;70(11):1835-1846. doi: 10.1002/art.40566. Epub 2018 Sep 24.

8.

Advances in Serodiagnostic Testing for Lyme Disease Are at Hand.

Branda JA, Body BA, Boyle J, Branson BM, Dattwyler RJ, Fikrig E, Gerald NJ, Gomes-Solecki M, Kintrup M, Ledizet M, Levin AE, Lewinski M, Liotta LA, Marques A, Mead PS, Mongodin EF, Pillai S, Rao P, Robinson WH, Roth KM, Schriefer ME, Slezak T, Snyder J, Steere AC, Witkowski J, Wong SJ, Schutzer SE.

Clin Infect Dis. 2018 Mar 19;66(7):1133-1139. doi: 10.1093/cid/cix943.

9.

Correction: Lyme borreliosis.

Steere AC, Franc S, Wormser GP, Hu LT, Branda JA, Hovius JWR, Li X, Mead PS.

Nat Rev Dis Primers. 2017 Aug 3;3:17062. doi: 10.1038/nrdp.2017.62.

PMID:
28770818
10.

Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints.

Pianta A, Arvikar SL, Strle K, Drouin EE, Wang Q, Costello CE, Steere AC.

J Clin Invest. 2017 Aug 1;127(8):2946-2956. doi: 10.1172/JCI93450. Epub 2017 Jun 26.

11.

Reply to Naktin.

Branda JA, Steere AC.

Clin Infect Dis. 2017 Nov 29;65(12):2157-2158. doi: 10.1093/cid/cix545. No abstract available.

12.

Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.

Branda JA, Strle K, Nigrovic LE, Lantos PM, Lepore TJ, Damle NS, Ferraro MJ, Steere AC.

Clin Infect Dis. 2017 Apr 15;64(8):1074-1080. doi: 10.1093/cid/cix043.

13.

T-Helper 17 Cell Cytokine Responses in Lyme Disease Correlate With Borrelia burgdorferi Antibodies During Early Infection and With Autoantibodies Late in the Illness in Patients With Antibiotic-Refractory Lyme Arthritis.

Strle K, Sulka KB, Pianta A, Crowley JT, Arvikar SL, Anselmo A, Sadreyev R, Steere AC.

Clin Infect Dis. 2017 Apr 1;64(7):930-938. doi: 10.1093/cid/cix002.

14.

MicroRNA Expression Shows Inflammatory Dysregulation and Tumor-Like Proliferative Responses in Joints of Patients With Postinfectious Lyme Arthritis.

Lochhead RB, Strle K, Kim ND, Kohler MJ, Arvikar SL, Aversa JM, Steere AC.

Arthritis Rheumatol. 2017 May;69(5):1100-1110. doi: 10.1002/art.40039.

15.

Lyme borreliosis.

Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, Li X, Mead PS.

Nat Rev Dis Primers. 2016 Dec 15;2:16090. doi: 10.1038/nrdp.2016.90. Review. Erratum in: Nat Rev Dis Primers. 2017 Aug 03;3:17062.

16.

Evidence of the Immune Relevance of Prevotella copri, a Gut Microbe, in Patients With Rheumatoid Arthritis.

Pianta A, Arvikar S, Strle K, Drouin EE, Wang Q, Costello CE, Steere AC.

Arthritis Rheumatol. 2017 May;69(5):964-975. doi: 10.1002/art.40003. Epub 2017 Apr 7.

17.

Reply.

Arvikar SL, Steere AC.

Arthritis Rheumatol. 2017 Mar;69(3):684-685. doi: 10.1002/art.39984. Epub 2017 Feb 2. No abstract available.

18.

Immunogenic HLA-DR-Presented Self-Peptides Identified Directly from Clinical Samples of Synovial Tissue, Synovial Fluid, or Peripheral Blood in Patients with Rheumatoid Arthritis or Lyme Arthritis.

Wang Q, Drouin EE, Yao C, Zhang J, Huang Y, Leon DR, Steere AC, Costello CE.

J Proteome Res. 2017 Jan 6;16(1):122-136. doi: 10.1021/acs.jproteome.6b00386. Epub 2016 Nov 7.

19.

Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease.

Arvikar SL, Crowley JT, Sulka KB, Steere AC.

Arthritis Rheumatol. 2017 Jan;69(1):194-202. doi: 10.1002/art.39866.

20.

Characterization of the early local immune response to Ixodes ricinus tick bites in human skin.

Glatz M, Means T, Haas J, Steere AC, Müllegger RR.

Exp Dermatol. 2017 Mar;26(3):263-269. doi: 10.1111/exd.13207. Epub 2017 Feb 9.

21.

Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States.

Cerar T, Strle F, Stupica D, Ruzic-Sabljic E, McHugh G, Steere AC, Strle K.

Emerg Infect Dis. 2016 May;22(5):818-27. doi: 10.3201/eid2205.151806.

22.

Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis.

Crowley JT, Strle K, Drouin EE, Pianta A, Arvikar SL, Wang Q, Costello CE, Steere AC.

J Autoimmun. 2016 May;69:24-37. doi: 10.1016/j.jaut.2016.02.005. Epub 2016 Feb 26.

23.

Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Lahey LJ, Panas MW, Mao R, Delanoy M, Flanagan JJ, Binder SR, Rebman AW, Montoya JG, Soloski MJ, Steere AC, Dattwyler RJ, Arnaboldi PM, Aucott JN, Robinson WH.

J Clin Microbiol. 2015 Dec;53(12):3834-41. doi: 10.1128/JCM.02111-15. Epub 2015 Oct 7.

24.

Annexin A2 is a target of autoimmune T and B cell responses associated with synovial fibroblast proliferation in patients with antibiotic-refractory Lyme arthritis.

Pianta A, Drouin EE, Crowley JT, Arvikar S, Strle K, Costello CE, Steere AC.

Clin Immunol. 2015 Oct;160(2):336-41. doi: 10.1016/j.clim.2015.07.005. Epub 2015 Jul 15.

25.

A Highly Expressed Human Protein, Apolipoprotein B-100, Serves as an Autoantigen in a Subgroup of Patients With Lyme Disease.

Crowley JT, Drouin EE, Pianta A, Strle K, Wang Q, Costello CE, Steere AC.

J Infect Dis. 2015 Dec 1;212(11):1841-50. doi: 10.1093/infdis/jiv310. Epub 2015 May 26.

26.

Diagnosis and treatment of Lyme arthritis.

Arvikar SL, Steere AC.

Infect Dis Clin North Am. 2015 Jun;29(2):269-80. doi: 10.1016/j.idc.2015.02.004. Review.

27.

Editorial commentary: what constitutes appropriate treatment of post-Lyme disease symptoms and other pain and fatigue syndromes?

Steere AC, Arvikar SL.

Clin Infect Dis. 2015 Jun 15;60(12):1783-5. doi: 10.1093/cid/civ187. Epub 2015 Apr 6. No abstract available.

PMID:
25852123
28.

Reply to Seligman et Al.

Strle K, Stupica D, Drouin EE, Steere AC, Strle F.

Clin Infect Dis. 2014 Sep 1;59(5):747-8. doi: 10.1093/cid/ciu343. Epub 2014 May 7. No abstract available.

PMID:
24812297
29.

Antibodies to endothelial cell growth factor and obliterative microvascular lesions in the synovium of patients with antibiotic-refractory lyme arthritis.

Londoño D, Cadavid D, Drouin EE, Strle K, McHugh G, Aversa JM, Steere AC.

Arthritis Rheumatol. 2014 Aug;66(8):2124-33. doi: 10.1002/art.38618.

30.

Reply to Parvu and Parvu.

Strle K, Stupica D, Drouin EE, Steere AC, Strle F.

Clin Infect Dis. 2014 Apr;58(8):1200. doi: 10.1093/cid/ciu062. Epub 2014 Jan 26. No abstract available.

PMID:
24470277
31.

Natural killer cells and natural killer T cells in Lyme arthritis.

Katchar K, Drouin EE, Steere AC.

Arthritis Res Ther. 2013 Nov 7;15(6):R183. doi: 10.1186/ar4373.

32.

Elevated levels of IL-23 in a subset of patients with post-lyme disease symptoms following erythema migrans.

Strle K, Stupica D, Drouin EE, Steere AC, Strle F.

Clin Infect Dis. 2014 Feb;58(3):372-80. doi: 10.1093/cid/cit735. Epub 2013 Nov 11.

33.

Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.

Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, Kawai T, Strle K, Steere AC.

Arthritis Res Ther. 2013;15(5):R109.

34.

Tick-specific borrelial antigens appear to be upregulated in American but not European patients with Lyme arthritis, a late manifestation of Lyme borreliosis.

Li X, Strle K, Wang P, Acosta DI, McHugh GA, Sikand N, Strle F, Steere AC.

J Infect Dis. 2013 Sep;208(6):934-41. doi: 10.1093/infdis/jit269. Epub 2013 Jun 12.

35.

Performance of United States serologic assays in the diagnosis of Lyme borreliosis acquired in Europe.

Branda JA, Strle F, Strle K, Sikand N, Ferraro MJ, Steere AC.

Clin Infect Dis. 2013 Aug;57(3):333-40. doi: 10.1093/cid/cit235. Epub 2013 Apr 16.

PMID:
23592827
36.

Reinfection versus relapse in Lyme disease.

Steere AC.

N Engl J Med. 2013 Mar 14;368(11):1064. doi: 10.1056/NEJMc1215615. No abstract available.

PMID:
23495391
37.

Dysregulation of CD4+CD25(high) T cells in the synovial fluid of patients with antibiotic-refractory Lyme arthritis.

Vudattu NK, Strle K, Steere AC, Drouin EE.

Arthritis Rheum. 2013 Jun;65(6):1643-53. doi: 10.1002/art.37910.

38.

Reinfection versus relapse in Lyme disease.

Steere AC.

N Engl J Med. 2012 Nov 15;367(20):1950-1. doi: 10.1056/NEJMe1211361. No abstract available.

PMID:
23150963
39.

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease.

Wormser GP, Schriefer M, Aguero-Rosenfeld ME, Levin A, Steere AC, Nadelman RB, Nowakowski J, Marques A, Johnson BJ, Dumler JS.

Diagn Microbiol Infect Dis. 2013 Jan;75(1):9-15. doi: 10.1016/j.diagmicrobio.2012.09.003. Epub 2012 Oct 11.

40.

A novel human autoantigen, endothelial cell growth factor, is a target of T and B cell responses in patients with Lyme disease.

Drouin EE, Seward RJ, Strle K, McHugh G, Katchar K, Londoño D, Yao C, Costello CE, Steere AC.

Arthritis Rheum. 2013 Jan;65(1):186-96. doi: 10.1002/art.37732.

41.

Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.

Strle K, Shin JJ, Glickstein LJ, Steere AC.

Arthritis Rheum. 2012 May;64(5):1497-507. doi: 10.1002/art.34383.

42.

Antiscience and ethical concerns associated with advocacy of Lyme disease.

Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Shapiro ED, Sood SK, Steere AC, Weinstein A, Wormser GP.

Lancet Infect Dis. 2011 Sep;11(9):713-9. doi: 10.1016/S1473-3099(11)70034-2.

43.

Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.

Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ.

Clin Infect Dis. 2011 Sep;53(6):541-7. doi: 10.1093/cid/cir464.

PMID:
21865190
44.

Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.

Strle K, Jones KL, Drouin EE, Li X, Steere AC.

Am J Pathol. 2011 Jun;178(6):2726-39. doi: 10.1016/j.ajpath.2011.02.018.

45.

Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis.

Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC.

Arthritis Rheum. 2011 Aug;63(8):2238-47. doi: 10.1002/art.30384.

46.

Multiplex immunoassay for Lyme disease using VlsE1-IgG and pepC10-IgM antibodies: improving test performance through bioinformatics.

Porwancher RB, Hagerty CG, Fan J, Landsberg L, Johnson BJ, Kopnitsky M, Steere AC, Kulas K, Wong SJ.

Clin Vaccine Immunol. 2011 May;18(5):851-9. doi: 10.1128/CVI.00409-10. Epub 2011 Mar 2.

47.

Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis.

Steere AC, Drouin EE, Glickstein LJ.

Clin Infect Dis. 2011 Feb;52 Suppl 3:s259-65. doi: 10.1093/cid/ciq117. Review.

48.

Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis.

Seward RJ, Drouin EE, Steere AC, Costello CE.

Mol Cell Proteomics. 2011 Mar;10(3):M110.002477. doi: 10.1074/mcp.M110.002477. Epub 2010 Nov 16.

49.

Role of adrenomedullin in Lyme disease.

Marre ML, Darcy CT, Yinh J, Akira S, Uematsu S, Steere AC, Hu LT.

Infect Immun. 2010 Dec;78(12):5307-13. doi: 10.1128/IAI.00630-10. Epub 2010 Oct 4.

50.

Borrelia burgdorferi stimulation of chemokine secretion by cells of monocyte lineage in patients with Lyme arthritis.

Shin JJ, Strle K, Glickstein LJ, Luster AD, Steere AC.

Arthritis Res Ther. 2010;12(5):R168. doi: 10.1186/ar3128. Epub 2010 Sep 9.

Supplemental Content

Loading ...
Support Center